Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 February, 2018 05:19 IST
Zydus Cadila gets USFDAs final nod for Desvenlafaxine ER tablets
Source: IRIS | 12 Oct, 2017, 01.10PM
Comments  |  Post Comment

Zydus Cadila has received the final approval from the U.S. Food & Drug Administration (USFDA) to market Desvenlafaxine Extended-Release Tablets, 50 mg and 100 mg. The drug is used to treat major depression and will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.

The group now has more than 160 approvals and has so far filed over 300 ANDAs since the commencement of the filing process in FY 2003-04.

Total volume of shares traded on the bourses today was lower by 52.05% to 600,531 compared with 22-day average volume of 1,252,527.

Shares of the company gained Rs 8.65, or 1.76%, to trade at Rs 500.00. The total volume of shares traded was 34,356 at the BSE (12.58 p.m., Thursday).



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Dilip Buildcon secures EPC road project worth Rs 6.70 bn - 16-Feb-2018 15:39
BHEL commissions 18 MW hydro-electric project in Punjab - 16-Feb-2018 13:33
Reliance Communication update on asset monetization - 16-Feb-2018 12:06
8K Miles Software launches blockchain platform 8K Health Edge - 16-Feb-2018 10:16
Mahindra Group to invest Rs 1.76 bn in Zoomcar - 16-Feb-2018 10:06
India Grid Trust acquires 3 project SPVs - 16-Feb-2018 09:56
Larsen & Toubro bags orders worth Rs 15.85 bn - 15-Feb-2018 13:11
Rajesh Exports wins export order worth Rs 8.73 bn - 15-Feb-2018 12:36
Torrent Power secures wind power projects worth 499.8 MW - 15-Feb-2018 10:09
Torrent Power signs agreement with Siemens Gamesa Renewable Power - 15-Feb-2018 10:08
Zee Learn inks pact to invest Rs 2 bn in MT Educare - 15-Feb-2018 10:01
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer